Medicure (OTCMKTS:MCUJF) Announces Quarterly Earnings Results

Medicure (OTCMKTS:MCUJF) posted its quarterly earnings data on Wednesday. The company reported ($0.09) EPS for the quarter, Zacks reports. Medicure had a negative net margin of 5.70% and a negative return on equity of 6.65%.

Medicure Stock Up 3.8%

Shares of MCUJF traded up $0.03 during trading hours on Wednesday, reaching $0.95. The company’s stock had a trading volume of 13,620 shares, compared to its average volume of 3,274. The company has a 50 day moving average of $0.81 and a two-hundred day moving average of $0.81. The company has a quick ratio of 1.06, a current ratio of 1.48 and a debt-to-equity ratio of 0.03. The firm has a market cap of $9.94 million, a price-to-earnings ratio of -9.52 and a beta of 1.04. Medicure has a 1-year low of $0.44 and a 1-year high of $0.96.

Medicure Company Profile

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.